Challenging paradigms in lymphoma treatment
نویسندگان
چکیده
منابع مشابه
Diffuse large B-cell lymphoma: changing treatment paradigms.
Diffuse large B-cell lymphoma (DLBCL) was first cured with anthracycline-based chemotherapy in the 1970s. In the late 1990s, the addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy increased 10-year overall survival by approximately 15%. Two decades of variations on chemotherapy regimens and dosing schedules and upfront transplant have demonst...
متن کاملBacille Calmette–Guérin dosage; challenging dogmas and changing paradigms
http://dx.doi.org/10.1016/j.aju.2015.09.006 2090-598X 2015 Arab Association of Urology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). A ‘dogma’ is defined as a belief that is proposed by authority figures to be ‘true’ even though no or marginal data exist to support the belief. Since Mora...
متن کاملPrimary Hepatic Lymphoma: A Challenging Diagnosis
Introduction. Primary hepatic lymphoma is an unusual malignancy and is very difficult to diagnose promptly. An intrigue case presenting with cholestatic jaundice is reviewed and main disease characteristics are further discussed. Case Report. A 70-year-old male presented with dull right upper quadrant abdominal pain and mild cholestatic jaundice. Initial evaluation revealed mildly elevated live...
متن کاملTreatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children
Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and radiation. The current challenge is to determine how much therapy is needed to improve survival and how to adapt treatment to the patient to prevent these long term toxicities. T...
متن کاملParadigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma
Burkitt lymphoma (BL) is a very aggressive subtype of non-Hodgkin's lymphoma that occurs with higher frequency in patients with HIV/AIDS. Patients with HIV-related BL (HIV-BL) are usually treated with high-intensity, multi-agent chemotherapy regimens. The addition of the monoclonal antibody Rituximab to chemotherapy has also been studied in this setting. The potential risks and benefits of comm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2004
ISSN: 0923-7534
DOI: 10.1093/annonc/mdh094